Streetbeat News

Stock Prices

TEVA

Teva Pharmaceuticals presented positive results from its Phase 3 SOLARIS trial for TEV-'749, a schizophrenia treatment, showing improvements in social functioning and quality of life. Additionally, real-world analyses of UZEDY highlighted high adherence among patients with treatment barriers.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 7:01 pm

VIAV

Viavi Solutions (NASDAQ:VIAV) has received mixed analyst ratings over the past three months, with a recent positive shift in average price targets. Analysts have raised and lowered ratings, reflecting diverse perspectives on the company's performance. Viavi faces challenges with declining revenue, low net margins, and below-average returns on equity and assets. However, it maintains a balanced debt approach.

Portfolio Pulse from Benzinga Insights

November 01, 2024 | 7:00 pm

ACLS

Axcelis Technologies (NYSE:ACLS) has seen a 14.48% decrease in its short percent of float, now at 8.09%. This indicates a potential shift in market sentiment as fewer shares are being shorted. The company's short interest is higher than its peers, which average 6.78%.

Portfolio Pulse from Benzinga Insights

November 01, 2024 | 7:00 pm

INVH

Analysts have varied opinions on Invitation Homes (NYSE:INVH), with recent ratings showing a mix of bullish, somewhat bullish, and indifferent sentiments. The average 12-month price target has increased slightly to $38.17. Analysts have adjusted their ratings and price targets, reflecting their response to market conditions and company performance. Invitation Homes has a strong market position with a significant portfolio of single-family rental homes, but faces challenges in revenue growth and return on equity.

Portfolio Pulse from Benzinga Insights

November 01, 2024 | 7:00 pm

FLR

Fluor's short interest has decreased by 13.64%, with 6.04 million shares sold short, representing 4.56% of its float. This is lower than its peers' average of 5.16%. The decrease in short interest may indicate a more bullish sentiment towards Fluor.

Portfolio Pulse from Benzinga Insights

November 01, 2024 | 7:00 pm

NUE

Nucor's short interest has decreased by 5.9%, with 4.98 million shares sold short, representing 2.71% of its float. This is lower than its peers' average of 4.59%. The decrease in short interest may indicate a more bullish sentiment towards Nucor.

Portfolio Pulse from Benzinga Insights

November 01, 2024 | 7:00 pm

OPCH

Option Care Health (NASDAQ:OPCH) has received mixed analyst ratings over the past three months, with a shift towards more bullish sentiments recently. Analysts have lowered their 12-month price targets, with an average target of $33.8, down from $39.00. Despite this, the company shows strong financial performance with significant revenue growth, high net margins, and efficient debt management.

Portfolio Pulse from Benzinga Insights

November 01, 2024 | 7:00 pm

JWSM

Trading of Jaws Mustang Acquisition Corp. (JWSM) shares has been halted pending news. This could indicate a significant announcement or event related to the company.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 7:00 pm